Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HOON DSB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Essner, R; Huynh, Y; Nguyen, T; Rose, DM; Kojima, M; Hoon, DSB
      Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: A possible mechanism for cytokine-based therapy

      JOURNAL OF GASTROINTESTINAL SURGERY
    2. Bilchik, AJ; Saha, S; Wiese, D; Stonecypher, JA; Wood, TF; Sostrin, S; Turner, RR; Wang, HJ; Morton, DL; Hoon, DSB
      Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial

      JOURNAL OF CLINICAL ONCOLOGY
    3. Turner, RR; Giuliano, AE; Hoon, DSB; Glass, EC; Krasne, DL
      Pathologic examination of sentinel lymph node for breast carcinoma

      WORLD JOURNAL OF SURGERY
    4. Hoon, DSB; Kuo, CT; Wascher, RA; Fournier, P; Wang, HJ; O'Day, SJ
      Molecular detection of metastatic melanoma cells in cerebrospinal fluid inmelanoma patients

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    5. Miyashiro, I; Kuo, C; Huynh, K; Iida, A; Morton, D; Bilchik, A; Giuliano, A; Hoon, DSB
      Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes

      CLINICAL CHEMISTRY
    6. Taback, B; Fujiwara, Y; Wang, HJ; Foshag, LJ; Morton, DL; Hoon, DSB
      Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients

      CANCER RESEARCH
    7. Kobayashi, H; Song, YS; Hoon, DSB; Appella, E; Celis, E
      Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles

      CANCER RESEARCH
    8. Wascher, RA; Bostick, PJ; Huynh, KT; Turner, R; Qi, K; Giuliano, AE; Hoon, DSB
      Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes

      BRITISH JOURNAL OF CANCER
    9. Hoon, DSB; Kuo, CT; Wen, SH; Wang, H; Metelitsa, L; Reynolds, CP; Seeger, RC
      Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

      AMERICAN JOURNAL OF PATHOLOGY
    10. Nakayama, T; Taback, B; Turner, R; Morton, DL; Hoon, DSB
      Molecular clonality of in-transit melanoma metastasis

      AMERICAN JOURNAL OF PATHOLOGY
    11. Fujiwara, Y; Hoon, DSB
      Microsatellite analysis of melanoma lesions using (CA)(13) oligonucleotides as an internal probe

      INTERNATIONAL JOURNAL OF ONCOLOGY
    12. Fujii, S; Huang, S; Fong, TC; Ando, D; Burrows, F; Jolly, DJ; Nemunaitis, J; Hoon, DSB
      Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients

      CANCER GENE THERAPY
    13. Fujiwara, Y; Hoon, DSB; Yamada, T; Umeshita, K; Gotoh, M; Sakon, M; Nishisho, I; Monden, M
      PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas

      JAPANESE JOURNAL OF CANCER RESEARCH
    14. Essner, R; Huynh, Y; Nguyen, T; Morton, DL; Hoon, DSB
      Functional interleukin 4 receptor and interleukin 2 receptor common gamma-chain on human non-small cell lung cancers: Novel targets for immune therapy

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    15. Hoon, DSB; Bostick, P; Kuo, C; Okamoto, T; Wang, HJ; Elashoff, R; Morton, DL
      Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence

      CANCER RESEARCH
    16. Bilchik, A; Miyashiro, M; Kelley, M; Kuo, C; Fujiwara, Y; Nakamori, S; Monden, M; Hoon, DSB
      Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay

      CANCER
    17. Zhou, WZ; Hoon, DSB; Huang, SKS; Fujii, S; Hashimoto, K; Morishita, R; Kaneda, Y
      RNA melanoma vaccine: Induction of antitumor immunity by human glycoprotein 100 mRNA immunization

      HUMAN GENE THERAPY
    18. Zhou, WZ; Kaneda, Y; Huang, SKS; Morishita, R; Hoon, DSB
      Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine

      GENE THERAPY
    19. Bostick, PJ; Morton, DL; Turner, RR; Huynh, KT; Wang, HJ; Elashoff, R; Essner, R; Hoon, DSB
      Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

      JOURNAL OF CLINICAL ONCOLOGY
    20. Fujiwara, Y; Chi, DDJ; Wang, HJ; Keleman, P; Morton, DL; Turner, R; Hoon, DSB
      Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients

      CANCER RESEARCH
    21. Takahashi, T; Cao, J; Hoon, DSB; Irie, RF
      Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancer

      BRITISH JOURNAL OF CANCER
    22. KUO CT; BOSTICK PJ; IRIE RF; MORTON DL; CONRAD AJ; HOON DSB
      ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL

      Clinical cancer research
    23. KUO CT; BOSTICK PJ; IRIE RF; MORTON DL; CONRAD AJ; HOON DSB
      ASSESSMENT OF MESSENGER-RNA OF BETA-1-]4-N-ACETYLGALACTOSAMINYLTRANSFERASE AS A MOLECULAR MARKER FOR METASTATIC MELANOMAL

      Clinical cancer research
    24. BOSTICK PJ; CHATTERJEE S; CHI DD; HUYNH KT; GIULIANO AE; COTE R; HOON DSB
      LIMITATIONS OF SPECIFIC REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION MARKERS IN THE DETECTION OF METASTASES IN THE LYMPH-NODES AND BLOODOF BREAST-CANCER PATIENTS

      Journal of clinical oncology
    25. HOON DSB; OKAMOTO T; WANG HJ; ELASHOFF R; NIZZE AJ; FOSHAG LJ; GAMMON G; MORTON DL
      IS THE SURVIVAL OF MELANOMA PATIENTS RECEIVING POLYVALENT MELANOMA CELL VACCINE LINKED TO THE HUMAN-LEUKOCYTE ANTIGEN PHENOTYPE OF PATIENTS

      Journal of clinical oncology
    26. TAKAHASHI T; CONFORTI A; KIKUMOTO Y; HOON DSB; MORTON DL; IRIE RF
      AUGMENTATION OF IGM ANTIBODY TO GP43 TUMOR-ASSOCIATED ANTIGEN PEPTIDEBY MELANOMA CELL VACCINE

      Journal of clinical immunology
    27. NISHINAKA Y; HOON DSB; IRIE RF
      HUMAN-IGM ANTIBODIES TO TUMOR-ASSOCIATED GANGLIOSIDES SHARE VHIII (V3-23) AND VKIV FAMILY SUBGROUPS

      Immunogenetics (New York)
    28. BOSTICK PJ; HOON DSB; COTE RJ
      DETECTION OF CARCINOEMBRYONIC ANTIGEN MESSENGER-RNA IN LYMPH-NODES FROM PATIENTS WITH COLORECTAL-CANCER

      The New England journal of medicine
    29. HUANG SKS; OKAMOTO T; MORTON DL; HOON DSB
      ANTIBODY-RESPONSES TO MELANOMA MELANOCYTE AUTOANTIGENS IN MELANOMA PATIENTS/

      Journal of investigative dermatology
    30. Okamoto, T; Irie, RF; Fujii, S; Huang, SKS; Nizze, AJ; Morton, DL; Hoon, DSB
      Anti-tyrosinase-related protein-2 immune response in vitiligo patients andmelanoma patients receiving active-specific immunotherapy

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    31. BOSTICK PJ; HUYNH KT; SARANTOU T; TURNER RR; QI K; GIULIANO AE; HOON DSB
      DETECTION OF METASTASES IN SENTINEL LYMPH-NODES OF BREAST-CANCER PATIENTS BY MULTIPLE-MARKER RT-PCR

      International journal of cancer
    32. OCONNELL CD; JUHASZ A; KUO C; REEDER DJ; HOON DSB
      DETECTION OF TYROSINASE MESSENGER-RNA IN MELANOMA BY REVERSE TRANSCRIPTION-PCR AND ELECTROCHEMILUMINESCENCE

      Clinical chemistry
    33. ESSNER R; KUO CT; WANG HJ; WEN DR; TURNER RR; NGUYEN T; HOON DSB
      PROGNOSTIC IMPLICATIONS OF P53 OVEREXPRESSION IN CUTANEOUS MELANOMA FROM SUN-EXPOSED AND NONEXPOSED SITES

      Cancer
    34. ZHANG ZQ; IRIE RF; CHI DDJ; HOON DSB
      CELLULAR IMMUNO-PCR - DEFECTION OF A CARBOHYDRATE TUMOR-MARKER

      The American journal of pathology
    35. TAKAHASHI T; IRIE RF; NISHINAKA Y; HOON DSB
      707-AP PEPTIDE RECOGNIZED BY HUMAN-ANTIBODY INDUCES HUMAN-LEUKOCYTE ANTIGEN A2-RESTRICTED CYTOTOXIC T-LYMPHOCYTE KILLING OF MELANOMA

      Clinical cancer research
    36. OKAMOTO T; KANEDA Y; YUZUKI D; HUANG SKS; CHI DDJ; HOON DSB
      INDUCTION OF ANTIBODY-RESPONSE TO HUMAN TUMOR-ANTIGENS BY GENE-THERAPY USING A FUSIGENIC VIRAL LIPOSOME VACCINE

      Gene therapy
    37. TAKAHASHI T; IRIE RF; MORTON DL; HOON DSB
      RECOGNITION OF GP43 TUMOR-ASSOCIATED ANTIGEN PEPTIDE BY BOTH HLA-A2 RESTRICTED CTL LINES AND ANTIBODIES FROM MELANOMA PATIENTS

      Cellular immunology
    38. SARANTOU T; CHI DDJ; GARRISON DA; CONRAD AJ; SCHMID P; MORTON DL; HOON DSB
      MELANOMA-ASSOCIATED ANTIGENS AS MESSENGER-RNA DETECTION MARKERS FOR MELANOMA

      Cancer research
    39. CHI DDJ; MERCHANT RE; RAND R; CONRAD AJ; GARRISON D; TURNER R; MORTON DL; HOON DSB
      MOLECULAR-DETECTION OF TUMOR-ASSOCIATED ANTIGENS SHARED BY HUMAN CUTANEOUS MELANOMAS AND GLIOMAS

      The American journal of pathology
    40. HOON DSB; IRIE RF
      CURRENT STATUS OF HUMAN-MELANOMA VACCINES - CAN THEY CONTROL MALIGNANT-MELANOMA

      Biodrugs
    41. HOON DSB; GARRISON D; CHI DD; CONRAD AJ; RAND RW; MORTON DL; MERCHANT RE
      MOLECULAR-DETECTION OF TUMOR-ASSOCIATED ANTIGENS SHARED BY HUMAN MELANOMAS AND GLIOMAS

      The FASEB journal
    42. UCHIYAMA A; ESSNER R; DOI F; NGUYEN T; RAMMING KP; NAKAMURA T; MORTON DL; HOON DSB
      INTERLEUKIN-4 INHIBITS HEPATOCYTE GROWTH FACTOR-INDUCED INVASION AND MIGRATION OF COLON CARCINOMAS

      Journal of cellular biochemistry
    43. HOON DSB; SARANTOU T; DOI F; CHI DDJ; KUO C; CONRAD AJ; SCHMID P; TURNER R; GUILIANO A
      DETECTION OF METASTATIC BREAST-CANCER BY BETA-HCG POLYMERASE CHAIN-REACTION

      International journal of cancer
    44. DOI F; CHI DDJ; CHARUWORN BB; CONRAD AJ; RUSSELL J; MORTON DL; HOON DSB
      DETECTION OF BETA-HUMAN CHORIONIC-GONADOTROPIN MESSENGER-RNA AS A MARKER FOR CUTANEOUS MALIGNANT-MELANOMA

      International journal of cancer
    45. HOON DSB; WANG Y; DALE PS; CONRAD AJ; SCHMID P; GARRISON D; KUO C; FOSHAG LJ; NIZZE AJ; MORTON DL
      DETECTION OF OCCULT MELANOMA-CELLS IN BLOOD WITH A MULTIPLE-MARKER POLYMERASE CHAIN-REACTION ASSAY

      Journal of clinical oncology
    46. MORIOKA N; KIKUMOTO Y; HOON DSB; MORTON DL; IRIE RF
      CYTOTOXIC T-CELL RECOGNITION OF A HUMAN-MELANOMA DERIVED PEPTIDE WITHA CARBOXYL-TERMINAL ALANINE-PROLINE SEQUENCE

      Molecular immunology
    47. HOON DSB; YUZUKI D; HAYASHIDA M; MORTON DL
      MELANOMA PATIENTS IMMUNIZED WITH MELANOMA CELL VACCINE INDUCE ANTIBODY-RESPONSES TO RECOMBINANT MAGE-1 ANTIGEN

      The Journal of immunology
    48. HOON DSB; DOI F; GIULIANO AE; SCHMID P; CONRAD AJ
      THE DETECTION OF BREAST-CARCINOMA MICROMETASTASES IN AXILLARY LYMPH-NODES BY MEANS OF REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION

      Cancer
    49. MORISAKI T; MORTON DL; UCHIYAMA A; YUZUKI D; BARTH A; HOON DSB
      CHARACTERIZATION AND AUGMENTATION OF CD4-CELL LINES AGAINST MELANOMA(CYTOTOXIC T)

      Cancer immunology and immunotherapy
    50. MORIOKA N; KIKUMOTO Y; HOON DSB; MORTON DL; IRIE RF
      A DECAPEPTIDE (GLN-ASP-LEU-THR-MET-LYS-TYR-GLN-ILE-PHE) FROM HUMAN-MELANOMA IS RECOGNIZED BY CTL IN MELANOMA PATIENTS

      The Journal of immunology
    51. MORISAKI T; UCHIYAMA A; YUZUKI D; ESSNER R; MORTON DL; HOON DSB
      INTERLEUKIN-4 REGULATES G(1) CELL-CYCLE PROGRESSION IN GASTRIC-CARCINOMA CELL

      Cancer research
    52. BARTH A; HOON DSB; FOSHAG LJ; NIZZE JA; FAMATIGA E; OKUN E; MORTON DL
      POLYVALENT MELANOMA CELL VACCINE INDUCES DELAYED-TYPE HYPERSENSITIVITY AND IN-VITRO CELLULAR IMMUNE-RESPONSE

      Cancer research
    53. HOON DSB; HAYASHI Y; MORISAKI T; FOSHAG LJ; MORTON DL
      INTERLEUKIN-4 PLUS TUMOR-NECROSIS-FACTOR-ALPHA AUGMENTS THE ANTIGENICITY OF MELANOMA-CELLS

      Cancer immunology and immunotherapy
    54. HOON DSB; OKUN E; NEUWIRTH H; MORTON DL; IRIE RF
      ABERRANT EXPRESSION OF GANGLIOSIDES IN HUMAN RENAL-CELL CARCINOMAS

      The Journal of urology
    55. HOON DSB; WANG Y; SZE L; KANDA H; WATANABE T; MORRISON SL; MORTON DL; IRIE RF
      MOLECULAR-CLONING OF A HUMAN MONOCLONAL-ANTIBODY REACTIVE TO GANGLIOSIDE-G(M3) ANTIGEN ON HUMAN CANCERS

      Cancer research
    56. HAYASHI Y; HOON DSB; FOSHAG LJ; PARK MS; TERASAKI PI; MORTON DL
      A PRECLINICAL MODEL TO ASSESS THE ANTIGENICITY OF AN HLA-A2 MELANOMA CELL VACCINE

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 10:58:24